[1] Clemente A, Renzulli M, Reginelli A, et al. Chronic prostatitis/pelvic pain syndrome: MRI findings and clinical correlations[J].Andrologia,2019,51(9):e13361.DOI:10.1111/and.13361.
[2] Moon SK, You MW, Lim JW. Granulomatous prostatitis mimicking prostate cancer[J].Urology,2020,137:e3-e5.DOI:10.1016/j.urology.2019.12.028.
[3] Han C, Zhu L, Liu X, et al. Differential diagnosis of uncommon prostate diseases: combining mpMRI and clinical information[J].Insights Imaging,2021,12(1):79.DOI:10.1186/s13244-021-01024-3.
[4] Sureka B, Elhence P, Khera PS, et al. Quantitative contrast-enhanced perfusion kinetics in multiparametric MRI in differentiating prostate cancer from chronic prostatitis: results from a pilot study[J].Br J Radiol,2019,92(1100):20190181.DOI:10.1259/bjr.20190181.
[5] Shakur A, Hames K, O'Shea A, et al. Prostatitis: imaging appearances and diagnostic considerations[J].Clin Radiol,2021,76(6):416-426.DOI:10.1016/j.crad.2021.01.007.
[6] Merat S, Blümlein T, Klarhöfer M, et al. Impact of chronic prostatitis on the PI-RADS score 3: proposal for the addition of a novel binary suffix[J].Diagnostics (Basel),2021,11(4):623.DOI:10.3390/diagnostics11040623.
[7] Turkbey B, Rosenkrantz AB, Haider MA, et al. Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2[J].Eur Urol,2019,76(3):340-351.DOI:10.1016/j.eururo.2019.02.033.
[8] Barrett T, Rajesh A, Rosenkrantz AB, et al. PI-RADS version 2.1: one small step for prostate MRI[J].Clin Radiol,2019,74(11):841-852.DOI:10.1016/j.crad.2019.05.019.
[9] Tamada T, Kido A, Yamamoto A, et al. Comparison of biparametric and multiparametric MRI for clinically significant prostate cancer detection with PI-RADS version 2.1[J].J Magn Reson Imaging,2021,53(1):283-291.DOI:10.1002/jmri.27283.
[10] Peker E, Sonmez DY, Akkaya HE, et al. Diagnostic performance of multiparametric MR imaging at 3.0 tesla in discriminating prostate cancer from prostatitis: a histopathologic correlation[J].Eurasian J Med,2019,51(1):31-37.DOI:10.5152/eurasianjmed.2018.18195.
[11] 郭吉锋,纪志英,解丙坤,等. T2WI联合DWI及DCE对外周带慢性前列腺炎与前列腺癌的诊断效能分析[J]. 磁共振成像,2020,11(12):1182-1185.DOI:10.12015/issn.1674- 8034.2020.12.023.
[12] 李鹏,高媛媛,黄英,等. DWI和DCE-MRI对外周带不同类型T2WI低信号慢性前列腺炎的诊断价值[J]. 中国医学计算机成像杂志,2021,27(5):425-430.DOI:10.3969/j.issn. 1006-5741.2021.05.010.
[13] Parra NA, Lu H, Choi J, et al. Habitats in DCE-MRI to predict clinically significant prostate cancers[J].Tomography,2019,5(1):68-76.DOI:10.18383/j.tom.2018. 00037.
[14] Lebovici A, Csutak C, Popa P, et al. Magnetic resonance imaging characteristics of chronic prostatitis in patients under the age of 50: is it more than the eye can see?[J].Acta Radiol,2022,63(6):839-846.DOI:10.1177/02841851211010397.
[15] Otti VC, Miller C, Powell RJ, et al. The diagnostic accuracy of multiparametric magnetic resonance imaging before biopsy in the detection of prostate cancer[J].BJU Int,2019,123(1):82-90.DOI:10.1111/bju.14420.
|